Role of the TGF-β/BMP-7/Smad pathways in renal diseases

XM Meng, ACK Chung, HY Lan - Clinical science, 2013 - portlandpress.com
TGF-β (transforming growth factor-β) and BMP-7 (bone morphogenetic protein-7), two key
members in the TGF-β superfamily, play important but diverse roles in CKDs (chronic kidney …

Epithelial-to-mesenchymal transition in diabetic nephropathy: fact or fiction?

I Loeffler, G Wolf - Cells, 2015 - mdpi.com
The pathophysiology of diabetic nephropathy (DN), one of the most serious complications in
diabetic patients and the leading cause of end-stage renal disease worldwide, is complex …

METTL14-regulated PI3K/Akt signaling pathway via PTEN affects HDAC5-mediated epithelial–mesenchymal transition of renal tubular cells in diabetic kidney disease

Z Xu, K Jia, H Wang, F Gao, S Zhao, F Li, J Hao - Cell death & disease, 2021 - nature.com
Abstract Histone deacetylase 5 (HDAC5) belongs to class II HDAC subfamily and is reported
to be increased in the kidneys of diabetic patients and animals. However, little is known …

[HTML][HTML] Polysulfide-mediated sulfhydration of SIRT1 prevents diabetic nephropathy by suppressing phosphorylation and acetylation of p65 NF-κB and STAT3

HJ Sun, SP Xiong, X Cao, L Cao, MY Zhu, ZY Wu… - Redox biology, 2021 - Elsevier
Diabetic kidney disease is known as a major cause of chronic kidney disease and end stage
renal disease. Polysulfides, a class of chemical agents with a chain of sulfur atoms, are …

Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes

K Nagaishi, Y Mizue, T Chikenji, M Otani, M Nakano… - Scientific reports, 2016 - nature.com
Bone marrow-derived mesenchymal stem cells (MSCs) have contributed to the improvement
of diabetic nephropathy (DN); however, the actual mediator of this effect and its role has not …

Transforming growth factor-β and the progression of renal disease

I Loeffler, G Wolf - Nephrology Dialysis Transplantation, 2014 - academic.oup.com
Transforming growth factor-β (TGF-β) is a profibrotic cytokine found in chronic renal
diseases, which initiates and modulates a variety of pathophysiological processes. It is …

Transforming growth factor-β1 and diabetic nephropathy

AS Chang, CK Hathaway… - American Journal of …, 2016 - journals.physiology.org
Transforming growth factor-β1 (TGF-β1) is established to be involved in the pathogenesis of
diabetic nephropathy. The diabetic milieu enhances oxidative stress and induces the …

TGF-β: the connecting link between nephropathy and fibrosis

B Sutariya, D Jhonsa, MN Saraf - Immunopharmacology and …, 2016 - Taylor & Francis
Renal fibrosis is the usual outcome of an excessive accumulation of extracellular matrix
(ECM) that frequently occurs in membranous and diabetic nephropathy. The result of renal …

Organ fibrosis and autoimmunity: the role of inflammation in TGFβ-dependent EMT

M Sisto, D Ribatti, S Lisi - Biomolecules, 2021 - mdpi.com
Recent advances in our understanding of the molecular pathways that control the link of
inflammation with organ fibrosis and autoimmune diseases point to the epithelial to …

Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis

K Kanasaki, G Taduri, D Koya - Frontiers in endocrinology, 2013 - frontiersin.org
Kidney disease associated with diabetes mellitus is a major health problem worldwide.
Although established therapeutic strategies, such as appropriate blood glucose control …